Pain is an issue in renal impairment [3]

British Medical Journal

Volumn 332, Issue 7539, 2006, Pages 488-489

  Reid, Colette ^a   Gibbins, Jane ^a   Hanks, Geoffrey ^a  

^a BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; DEXTROPROPOXYPHENE; DRUG METABOLITE; FENTANYL; HYDROMORPHONE; MORPHINE; NALOXONE; OPIATE; PETHIDINE;

DRUG ACCUMULATION; DRUG METABOLISM; DRUG TOXICITY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; OPIOID TOXICITY; PAIN; PRIORITY JOURNAL;

HUMANS; KIDNEY FAILURE, CHRONIC; NARCOTICS; PAIN;

EID: 33644777442     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.332.7539.488-b     Document Type: Letter

References (5)

1. Conway BR, Fogarty DG, Nelson WE, Doherty CC. Opiate toxicity in patients with renal failure. BMJ 2006;332:345-6. (44 February.)
2. Hanks GW, Hawkins C. Agreeing a gold standard in the management of cancer pain: the role of opioids. In: Hillier R, Finlay I, Welsh J, Miles A, eds. The effective management of cancer pain. London: Aesculapius Medical Press 2000:57-77.
3. Davison SN. Pain in hemodialysis patients: prevalence, cause, severity, and management Am J Kidney Dis 2003;42:1239-47.
4. Chambers EJ, Brown EA, Germain M. Supportive care for the renal patient. 1st ed. Oxford: Oxford University Press, 2004.
5. Kurella M, Bennett WM, Chertow GM. Analgesia in patients with ESRD: a review of the available evidence. Am J Kidney Dis 2003;42:217-28.